{"id":2374,"date":"2018-10-28T14:42:00","date_gmt":"2018-10-28T14:42:00","guid":{"rendered":"http:\/\/localhost\/projects\/horsesforsources\/rpa_gateway_drug_hfs-forbes_103018\/"},"modified":"2018-10-28T14:42:00","modified_gmt":"2018-10-28T14:42:00","slug":"rpa_gateway_drug_hfs-forbes_103018","status":"publish","type":"post","link":"https:\/\/www.horsesforsources.com\/rpa_gateway_drug_hfs-forbes_103018\/","title":{"rendered":"RPA is a gateway drug – and magically these guys agree too! Don’t you just love coincidences.."},"content":{"rendered":"
And here we go again… Our now-infamous headline “RPA is the gateway drug. AI is the drug…<\/a>” has now magically appeared on the Forbes website in an article entitled “Robotic Process Automation: A Gateway Drug to AI and Digital Transformation<\/a>” authored by Babson\u00a0Professor Tom Davenport and Carla O’Dell, Chairman at AQPC:<\/p>\n